Cyonanz Kit
Product Images NDC 65862-899

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Cyonanz (NDC 65862-899). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Norethindroneethinyl Fig1)

The text describes a figure depicting Circulatory Disease Mortality Rates per 100,000 Women-Years by Age, Smoking Status, and Oral Contraceptive Use. The figure shows four groups - ZZZever-users who are non-smokers with Synthetic-controls who are smokers, Ever-users who are smokers with EIcontrls who are non-smokers. The mortality rates are represented on the Y-axis, while the age groups (15-24, 25-34, 35-44, 45-54) are represented on the X-axis. The adapted figure is from PM. Layde and V. Beral, ref. #12.*

FDA Label Image

Figure2 (Norethindroneethinyl Fig2)

This is a list of different studies conducted using various cohorts to evaluate the effects of contraceptives on the subjects. The studies have measured the risk ratio (RR) or odds ratio (OR) for ever use or current use of contraceptives in relation to certain health outcomes. The text does not provide any detailed findings or conclusions of the studies.*

FDA Label Image

Figure3 (Norethindroneethinyl Fig3)

FDA Label Image

Figure4 (Norethindroneethinyl Fig4)

FDA Label Image

Figure5 (Norethindroneethinyl Fig5)

FDA Label Image

Figure6 (Norethindroneethinyl Fig6)

FDA Label Image

Package Label-principal Display Panel -0.5 mg/0.035 mg Pouch Label (Norethindroneethinyl Fig7)

FDA Label Image

Package Label-principal Display Panel -0.5 mg/0.035 mg Pouch Carton (Norethindroneethinyl Fig8)

FDA Label Image

Norethindroneethinyl Fig9

Cyonanz™ is an oral contraceptive tablet intended to prevent pregnancy. It contains Norethindrone and Ethinyl Estradiol Tablets, USP at a dosage of 0.5 mg/0.035 mg. It is important to note that the product does not protect against HIV infection (AIDS) and other sexually transmitted diseases. The usual dosage is one tablet daily as prescribed. Keep the product at 20° to 25°C (68° to 77°F) and out of reach of children. Each pouch contains a Summary Patient Pa. Code: TS/DRUGS/22/2009. Made in India.*

FDA Label Image

Chemical Structure (Norethindroneethinyl Str)

The text appears to be a chemical formula of Norethindrone Ethinyl estradiol. Norethindrone Ethinyl estradiol is a medication used as a birth control pill to prevent pregnancy.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.